Only 12% of Germans say they will have H1N1 vaccine after row blows up over safety of adjuvants

BMJ. 2009 Oct 21:339:b4335. doi: 10.1136/bmj.b4335.
No abstract available

Publication types

  • News

MeSH terms

  • Adjuvants, Immunologic / adverse effects
  • Germany
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza Vaccines / adverse effects*
  • Influenza, Human / prevention & control*

Substances

  • Adjuvants, Immunologic
  • Influenza Vaccines